Human Papillomavirus (HPV)

FIRST PUBLIC CONSULTATION: CALL FOR COMMENTS FROM 19 DECEMBER TO 30 JANUARY 2015

• Guidelines on a stability evaluation of vaccines for use in a controlled temperature chain
  pdf, 258kb
• Comment Form
  doc, 47kb

PUBLIC CONSULTATION: CALL FOR COMMENTS FROM 17 DECEMBER 2014 - 30 JANUARY 2015

• Guidance on scientific principles for regulatory risk assessment of biotherapeutic products
  pdf, 491kb
• Comment Form
  doc, 55kb

New Publications

• Main outcomes of the Expert Committee on Biological Standardization held from 13 to 17 October 2014
  pdf, 62kb
• Guidelines for procedures and data requirements for changes to approved vaccines
  pdf, 472kb
• Guidance of scientific principles for regulatory risk evaluation on finding an adventitious agent in a marketed vaccine
  pdf, 620kb
• Recommnendations to assure the quality, safety and efficacy of poliomyelitis vaccine (inactivated) Replacement of: TRS 910, Annex 2
  pdf, 608kb
• WHO Expert Committee on Biological Standardization: Technical Report Series 987 - 64th report
  jpg, 30kb
• WHO Expert Committee on Biological Standardization: Technical Report Series 980 - 63rd report

WHO Informal Consultation on Regulatory considerations for evaluation of Ebola Vaccines intended for emergency use, WHO/HQ Geneva, Switzerland, 18-19 March 2015

WHO Informal Consultation on Stability Evaluation of Vaccines for use in a Controlled Temperature Chain, WHO/HQ Geneva, Switzerland, 24–26 March 2015

WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WHO/HQ Geneva, Switzerland, 27–28 April 2015

WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WHO/HQ Geneva, Switzerland, 29–30 April 2015

Contacts

Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971